Skip to main content
. 2020 Apr 20;24:161. doi: 10.1186/s13054-020-02879-6

Table 3.

Estimates of the effect of covariates on 28- and 90-day mortality as evaluated in the eight Cox proportional hazards models

Variable Mortality at 28 days Mortality at 90 days
Model Incident delirium Days of delirium Days of coma Days of delirium or coma Incident delirium Days of delirium Days of coma Days of delirium or coma
Age 1.04 (1.03–1.06) 1.04 (1.03–1.06) 1.05 (1.03–1.06) 1.04 (1.03–1.05) 1.04 (1.03–1.05) 1.04 (1.03–1.05) 1.04 (1.03–1.05) 1.04 (1.03–1.05)
APACHE II score 1.07 (1.06–1.09) 1.07 (1.06–1.09) 1.07 (1.05–1.09) 1.07 (1.06–1.09) 1.07 (1.05–1.08) 1.07 (1.05–1.08) 1.06 (1.05–1.08) 1.06 (1.05–1.08)
Sepsis present 1.89 (1.46–2.43) 1.87 (1.45–2.42) 1.73 (1.33–2.24) 1.87 (1.45–2.42) 1.86 (1.48–2.33) 1.85 (1.47–2.33) 1.72 (1.36–2.17) 1.78 (1.41–2.25)
Mechanical ventilation use 2.81 (1.88–4.19) 2.77 (1.86–4.13) 2.24 (1.50–3.36) 2.49 (1.66–3.72) 2.16 (1.54–3.05) 2.14 (1.53–3.00) 1.83 (1.30–2.58) 1.95 (1.38–2.74)
ICU Length of Stay 0.97 (0.95–0.99) 0.97 (0.96–0.99) 0.92 (0.90–0.95) 0.95 (0.92–0.97) 1.00 (0.98–1.01) 1.00 (0.98–1.01) 0.97 (0.95–0.99) 0.98 (0.97–1.00)
Study Arm
 Haloperidol 2 mg 1.08 (0.78–1.49) 1.06 (0.76–1.47) 1.20 (0.87–1.66) 1.29 (0.93–1.78) 1.17 (0.88–1.56) 1.18 (0.89–1.58) 1.31 (0.98–1.74) 0.97 (0.76–1.25)
 Haloperidol 1 mg 1.18 (0.84–1.66) 1.16 (0.83–1.64) 1.12 (0.79–1.58) 1.21 (0.86–1.71) 1.15 (0.84–1.57) 1.15 (0.84–1.57) 1.16 (0.85–1.60) 0.99 (0.73–1.35)

Data is present as hazard ratios with their associated 95% confidence intervals